OR WAIT null SECS
Peter Keeling is CEO of Diaceutics Group. He can be reached at peter.keeling@diaceutics.com or 011 44 2890 875559.
Timely engagement is the key to expanding the use of companion diagnostics.
Partnerships between pharmaceutical (Rx) and diagnostic (Dx) companies are difficult to achieve because most managers don't understand what it takes to make them work.